DR. DEMETRIOS VAVVAS, M.D.,PHD
Medical Practice at Charles St, Boston, MA

License number
Massachusetts 216838
Category
Medical Practice
Type
Ophthalmology
Address
Address
243 Charles St, Boston, MA 02114
Phone
(617) 573-5589

Professional information

Demetrios Vavvas Photo 1

Demetrios Vavvas, Boston MA

Specialties:
Ophthalmology, Otolaryngology
Work:
Mass Eye & Ear Infirmary
243 Charles St, Boston, MA 02114
Education:
Boston University(1999)


Demetrios Vavvas Photo 2

Dr. Demetrios Vavvas, Boston MA - MD (Doctor of Medicine)

Specialties:
Ophthalmology
Address:
133 Brookline Ave, Boston 02215
(617) 421-1000 (Phone)
Gragoudas Lowenstein and Young MD
243 Charles St, Boston 02114
(617) 573-3515 (Phone)
151 Everett Ave, Chelsea 02150
Certifications:
Ophthalmology, 2005
Awards:
Healthgrades Honor Roll
Languages:
English, French, Greek
Hospitals:
133 Brookline Ave, Boston 02215
151 Everett Ave, Chelsea 02150
Gragoudas Lowenstein and Young MD
243 Charles St, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
Education:
Medical School
Boston University School Of Medicine
Graduated: 1999
Boston Med Center
Graduated: 2000
Harvard Ophthalmology
Graduated: 2003
Harvard Meei
Graduated: 2007


Demetrios Vavvas Photo 3

Methods And Compositions For Preserving Photoreceptor And Retinal Pigment Epithelial Cells

US Patent:
2013013, May 30, 2013
Filed:
Apr 23, 2011
Appl. No.:
13/642887
Inventors:
Demetrios Vavvas - Boston MA, US
Georgios Trichonas - Boston MA, US
Joan W. Miller - Winchester MA, US
Yusuke Murakami - Newton MA, US
International Classification:
A61K 38/00, A61K 31/40, A61K 31/4178
US Classification:
514 189
Abstract:
Provided are methods and compositions for maintaining the viability of photoreceptor cells and/or retinal pigment epithelial cells in a subject with an ocular disorder including, for example, age-related macular degeneration (AMD) (e.g., dry or neovascular AMD), retinitis pigmentosa (RP), or a retinal detachment. The viability of the photoreceptor cells and/or the retinal pigment epithelial cells can be preserved by administering a necrosis inhibitor either alone or in combination with an apoptosis inhibitor to a subject having an eye with the ocular condition. The compositions, when administered, maintain the viability of the cells, thereby minimizing the loss of vision or visual function associated with the ocular disorder.


Demetrios Vavvas Photo 4

Methods And Compositions For Preserving Retinal Ganglion Cells

US Patent:
2014002, Jan 23, 2014
Filed:
Oct 21, 2011
Appl. No.:
13/882932
Inventors:
Demetrios Vavvas - Boston MA, US
Joan W. Miller - Winchester MA, US
Maki Kayama - Tokyo, JP
International Classification:
A61K 31/4178, A61K 38/00
US Classification:
514 177, 514389
Abstract:
Provided are methods and compositions for maintaining the viability of retinal ganglion cells in a subject with an ocular disorder including, for example, glaucoma and optic nerve injury. The viability of the retinal ganglion cells can be preserved by administering a necrosis inhibitor either alone or in combination with an apoptosis inhibitor to a subject having an eye with the ocular condition. The compositions, when administered, maintain the viability of the cells and/or promote axon regeneration, thereby minimizing the loss of vision or visual function associated with the ocular disorder.